يعرض 1 - 10 نتائج من 53 نتيجة بحث عن '"Dominique A. Caugant"', وقت الاستعلام: 1.16s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
  7. 7

    المساهمون: Medical Microbiology and Infection Prevention, AII - Infectious diseases, Wellcome Trust, Meningitis Research Foundation [Bristol], The Wellcome Trust Sanger Institute [Cambridge], Public Health England North West [Manchester] (PHE), Public Health England [London], Manchester Royal Infirmary, University of Manchester [Manchester], University of Oxford [Oxford], Biodiversité et Epidémiologie des Bactéries pathogènes - Biodiversity and Epidemiology of Bacterial Pathogens, Institut Pasteur [Paris], Norwegian Institute of Public Health [Oslo] (NIPH), Pfizer, Centers for Disease Control and Prevention (CDC), University of Pittsburgh (PITT), Pennsylvania Commonwealth System of Higher Education (PCSHE), University College of London [London] (UCL), St George's, University of London, Serum Institute of India Pvt. Ltd. [Pune, India], Imperial College London, GlaxoSmithKline [Siena, Italy] (GSK), Sanofi Pasteur [Lyon, France], Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), University of Amsterdam [Amsterdam] (UvA), Amsterdam UMC, Instituto de Salud Carlos III [Madrid] (ISC), Ministry of Health [Riyadh], University of Oxford, Institut Pasteur [Paris] (IP), Amsterdam UMC - Amsterdam University Medical Center

    المصدر: Repisalud
    Instituto de Salud Carlos III (ISCIII)
    Journal of Infection
    Journal of infection, 81(4), 510-520. W.B. Saunders Ltd
    Journal of Infection, WB Saunders, 2020, 81 (4), pp.510-520. ⟨10.1016/j.jinf.2020.06.064⟩
    Journal of Infection, 2020, 81 (4), pp.510-520. ⟨10.1016/j.jinf.2020.06.064⟩

    وصف الملف: application/pdf

  8. 8
  9. 9

    المساهمون: Medical Microbiology and Infection Prevention, AII - Infectious diseases, Wellcome Trust

    المصدر: Eurosurveillance
    Euro surveillance, 24(14):1800245. Centre Europeen pour la Surveillance Epidemiologique du SIDA
    Repisalud
    Instituto de Salud Carlos III (ISCIII)

    وصف الملف: application/pdf

  10. 10

    المساهمون: Finlay Institute of Vaccines, Public Health England [London], Norwegian Institute of Public Health [Oslo] (NIPH), University of the East – Ramon Magsaysay Memorial Medical Center [Philippines], Faculty of Medicine [Hacettepe University], Hacettepe University = Hacettepe Üniversitesi, University of Bristol [Bristol], Université Laval [Québec] (ULaval), Eskisehir Osmangazi University, National Institute of Public Health = Instituto Nacional de Salud Pública [Cuernavaca, Mexique] (INSP), Ministry of Health [Riyadh], National Institute of Infectious Diseases [Tokyo], University of Cambridge [UK] (CAM), National Institute for Communicable Diseases [Johannesburg] (NICD), Central Research Institute of Epidemiology [Moscow], FCM Santa Casa de São Paulo School of Medical Sciences [São Paulo], Chinese Centre for Disease Control and Prevention, Meningitis Research Foundation [Bristol], Universität Zürich [Zürich] = University of Zurich (UZH), Örebro University Hospital [Örebro, Sweden], Centre National de Référence des Méningocoques et Haemophilus influenzae - National Reference Center Meningococci and Haemophilus influenzae (CNR), Institut Pasteur [Paris], Institute of Health Carlos III, R. Borrow, J. Lucidarme and X. Bai perform contract work for Public Health England on behalf of GSK, PATH, Sanofi Pasteur and Pfizer. M.K. Taha performs contract work for the Institut Pasteur funded by GSK, Pfizer and Sanofi Pasteur. S. Meiring has received grant funding for a meningococcal carriage study by Sanofi Pasteur. G. Enchaniz-Aviles has received support for research projects from GSK and Pfizer. J.A. Vázquez performs contract work for the Institute of Health Carlos III funded by GSK and Pfizer. P. De Wals has received research grants, and reimbursements of travel expenses from vaccine manufacturers including GSK, Novartis, Sanofi Pasteur, and Pfizer, as well as from governmental agencies including the Quebec Ministry of Health and Social Services, Health Canada, and the Public Health Agency of Canada. M.A.P. Sáfadi has received grants to support research projects and consultancy fees from GSK, Pfizer and Sanofi Pasteur. C. Trotter has received consulting fees from GSK and an honorarium from Sanofi-Pasteur for developing and delivering a modeling workshop at a previous GMI meeting. H. Christensen has received reimbursements of travel expenses and, for previous GMI meetings, honoraria, from Sanofi-Pasteur, consultancy fees from IMS Health and AstraZeneca all paid to her employer. She is supported by the NIHR Health Protection Research Unit in Evaluation of Interventions at the University of Bristol. The views expressed in this article are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care., Institut Pasteur [Paris] (IP), Sanofi Pasteur

    المصدر: Expert Review of Vaccines
    Expert Review of Vaccines, Expert Reviews (formerly Future Drugs), 2018, 18 (1), pp.15-30. ⟨10.1080/14760584.2019.1557520⟩
    Acevedo, R, Bai, X, Borrow, R, Caugant, D A, Carlos, J, Ceyhan, M, Christensen, H, Climent, Y, De Wals, P, Dinleyici, E C, Echaniz-Aviles, G, Hakawi, A, Kamiya, H, Karachaliou, A, Lucidarme, J, Meiring, S, Mironov, K, Sáfadi, M A P, Shao, Z, Smith, V, Steffen, R, Stenmark, B, Taha, M-K, Trotter, C, Vázquez, J A & Zhu, B 2019, ' The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide : epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations ', Expert Review of Vaccines, vol. 18, no. 1, pp. 15-30 . https://doi.org/10.1080/14760584.2019.1557520Test
    Expert Review of Vaccines, 2018, 18 (1), pp.15-30. ⟨10.1080/14760584.2019.1557520⟩
    Repisalud
    Instituto de Salud Carlos III (ISCIII)

    وصف الملف: application/pdf